176.45
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$175.26
Offen:
$175.26
24-Stunden-Volumen:
2.06M
Relative Volume:
0.18
Marktkapitalisierung:
$221.73B
Einnahmen:
$19.59B
Nettoeinkommen (Verlust:
$5.81B
KGV:
38.88
EPS:
4.538
Netto-Cashflow:
$5.55B
1W Leistung:
+8.00%
1M Leistung:
+23.60%
6M Leistung:
+92.46%
1J Leistung:
+138.91%
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Vergleichen Sie LRCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
LRCX
Lam Research Corp
|
176.53 | 220.13B | 19.59B | 5.81B | 5.55B | 4.538 |
|
ASML
Asml Holding Nv
|
1,060.95 | 410.26B | 35.54B | 10.43B | 9.71B | 26.71 |
|
AMAT
Applied Materials Inc
|
259.48 | 205.38B | 28.37B | 7.00B | 5.70B | 8.6741 |
|
KLAC
Kla Corp
|
1,268.53 | 166.30B | 12.52B | 4.24B | 3.87B | 31.85 |
|
TER
Teradyne Inc
|
198.09 | 30.89B | 2.86B | 443.08M | 456.83M | 2.7476 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Exchange Traded Concepts LLC Acquires 39,153 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research (LRCX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Is Lam Research (LRCX) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
Lam Research Target of Unusually Large Options Trading (NASDAQ:LRCX) - MarketBeat
Brokers Suggest Investing in Lam Research (LRCX): Read This Before Placing a Bet - Finviz
Lam Research Hits 52-Week High: Is the Stock Still Worth Buying? - The Globe and Mail
Legacy Wealth Asset Management LLC Purchases 8,270 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research (LRCX) Surges 4.6%: Is This an Indication of Further Gains? - Yahoo Finance
Lam Research (LRCX) Stock: Key News, Analyst Forecasts, and What to Watch Before the Dec. 22, 2025 Market Open - ts2.tech
Wedge Capital Management L L P NC Acquires 619,933 Shares of Lam Research Corporation $LRCX - MarketBeat
Viking Fund Management LLC Sells 37,000 Shares of Lam Research Corporation $LRCX - MarketBeat
Foster Victor Wealth Advisors LLC Has $27.46 Million Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Flputnam Investment Management Co. Buys 25,173 Shares of Lam Research Corporation $LRCX - MarketBeat
Perpetual Ltd Acquires 9,101 Shares of Lam Research Corporation $LRCX - MarketBeat
U.S. Capital Wealth Advisors LLC Grows Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research (LRCX) Stock After Hours Today (Dec. 19, 2025): What Happened After the Bell and What to Know Before the Next Market Open - ts2.tech
Why Is Lam Research (LRCX) Stock Soaring Today - Finviz
Lam Research (NASDAQ:LRCX) Stock Price Up 4.6% Following Analyst Upgrade - MarketBeat
Lam Research Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Lam Research Corp. stock outperforms competitors despite losses on the day - MSN
Lam Research shares rise following new analyst upgrades! - XTB.com
Lam Research (LRCX) Surges 6.27% as 3 Firms Turn Bullish - Finviz
Lam Research (LRCX) Just Flashed Golden Cross Signal: Do You Buy? - Finviz
Lam Research (NASDAQ:LRCX) Sets New 12-Month High Following Analyst Upgrade - MarketBeat
Lam Research, KLA enter 2026 with momentum due to AI infrastructure spending: Oppenheimer (LRCX:NASDAQ) - Seeking Alpha
Lam Research Corp stock hits all-time high at 169.72 USD - Investing.com Canada
Lam Research Corporation $LRCX Stock Position Lifted by Voya Investment Management LLC - MarketBeat
Investment Review: Is Lam Research Corporation stock dividend yield sustainable2025 Bull vs Bear & Long-Term Capital Growth Strategies - DonanımHaber
Lam Research (NASDAQ:LRCX) Shares Up 6.3% on Analyst Upgrade - MarketBeat
A Look Into Lam Research Inc's Price Over Earnings - Benzinga
Lam Research Stock Saw A Price Target Hike From B. Riley – What’s The Driving Factor? - Stocktwits
CEO Archer Sells 163,300 ($26.8M) Of Lam Research Corp [LRCX] - TradingView — Track All Markets
[Form 4] LAM RESEARCH CORP Insider Trading Activity - Stock Titan
Why Lam Research (LRCX) Stock Is Up Today - Finviz
Lam Research (LRCX) Jumps on Analyst Upgrades & Strong AI Demand | Dec 2025News and Statistics - IndexBox
Lam Research (NASDAQ:LRCX) Price Target Raised to $195.00 - MarketBeat
94,825 Shares in Lam Research Corporation $LRCX Bought by NatWest Group plc - MarketBeat
Montecito Bank & Trust Makes New $1.45 Million Investment in Lam Research Corporation $LRCX - MarketBeat
Lam Research Stock (LRCX) After Hours Today (Dec. 17, 2025): Why Shares Dropped, the Late Bounce, and What to Watch Before Tomorrow’s Open - ts2.tech
Lam Research (NASDAQ:LRCX) Shares Down 5.1%Time to Sell? - MarketBeat
Lam Research Announces Winners of Annual Collegiate Challenge - The Hans India
CEO Archer Files To Sell 163,300 Of Lam Research Corp [LRCX] - TradingView — Track All Markets
Lam Research (NASDAQ:LRCX) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat
Sanders Morris Harris LLC Acquires New Position in Lam Research Corporation $LRCX - MarketBeat
AI Chips Can’t Exist Without These 2 Underrated Tech Giants - Investing.com
Assenagon Asset Management S.A. Cuts Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
TruWealth Advisors LLC Takes Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Sold by Insight Wealth Strategies LLC - MarketBeat
Texas Permanent School Fund Corp Reduces Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Bought by Aaron Wealth Advisors LLC - MarketBeat
Lam Research Names Top Teams In India Systems Engineering Challenge - SMEStreet
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lam Research Corp-Aktie (LRCX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ARCHER TIMOTHY | President and CEO |
Dec 17 '25 |
Sale |
163.86 |
163,300 |
26,758,338 |
932,409 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):